by Stephanie Holmes | Nov 4, 2022 | Lupus Foundation of America, News & Events
New research out of Japan finds that a urinary kidney injury molecule-1 (u-KIM-1) level correlate with lupus nephritis (LN, lupus-related kidney disease) disease activity. KIM-1 is a recently discovered protein thought to be involved in kidney damage. u-KIM-1 refers...
by Stephanie Holmes | Oct 20, 2022 | Lupus Foundation of America, News & Events
Data from the Lupus Midwest Network (LUMEN) in Minnesota show that incidence and prevalence rates of lupus nephritis (LN, lupus-related kidney disease) have increased over the last 40 years. The findings also highlight the serious health risks associated with LN, and...
by Stephanie Holmes | Oct 19, 2022 | Lupus Foundation of America, News & Events
A new study examined the relationship between race, ethnicity and COVID-19 outcomes in people in the United States with lupus. Researchers found that Black and Hispanic individuals with lupus experienced more severe COVID-19 outcomes, which is consistent with the...
by Stephanie Holmes | Oct 19, 2022 | Lupus Foundation of America, News & Events
Biogen Inc. announced that the first person has been given the investigational drug litifilimab (also known as BIIB059), for the treatment of lupus skin disease (cutaneous lupus erythematosus (CLE)). Litifilimab is an anti-inflammatory medication (a drug used to fight...
by Stephanie Holmes | Oct 13, 2022 | Lupus Foundation of America
Our ambassador Melissa Osoria explains how she has benefited from our program Be Fierce. Take Control. since her lupus diagnosis.When I think about what Be Fierce. Take Control. means to me as an Afro-Latina, I think about the many times in my life I had to take...
